(Q35998003)

11 August 2017

1 reference

title

Bone disorders associated with the human immunodeficiency virus: pathogenesis and management (English)

1 reference

11 August 2017

Roula B Qaqish

1

1 reference

11 August 2017

Keri A Sims

series ordinal

2

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

24

1 reference

11 August 2017

issue

10

1 reference

11 August 2017

page(s)

1331-1346

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Clinical use of bone densitometry: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Host factors and the pathogenesis of HIV-induced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Molecular control of bone remodeling and osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Prospective, intensive study of metabolic changes associated with 48 weeks of amprenavir-based antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Bone remodelling in human immunodeficiency virus-1-infected patients. A histomorphometric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Bone mineral density in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Osteopenia in HIV-infected women prior to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Alterations in bone turnover in HIV-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor kappa B ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-gamma/RANKL cross-talk

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Select HIV protease inhibitors alter bone and fat metabolism ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Body composition changes in protease inhibitor-naive HIV-infected patients treated with two nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Osteoporosis prevention, diagnosis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Osteonecrosis in HIV: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Osteonecrosis in patients infected with human immunodeficiency virus: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Reduced bone mineral density in HIV-positive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

Alendronate for the Treatment of Osteoporosis in Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.14.1331.43150

10.1592/PHCO.24.14.1331.43150

21 January 2018

Identifiers

DOI

1 reference

release_nlj65vbrgres3atamhtbni7mr4

11 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nlj65vbrgres3atamhtbni7mr4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference